advertisement
|
|
|
|
|
advertisement
|
|
| |
Top Stories
Updates on COVID-19 vaccine candidates, FDA policies, company partnerships, and more.
/ read more /
The companies are entering into a license agreement to provide CSL Behring with exclusive global rights to etranacogene dezaparvovec, uniQure’s investigational gene therapy for patients with hemophilia B.
/ read more /
|
|
| |
Industry News
Efforts by regulators seek common approaches to clinical research and biopharmaceutical production needed to wipe out the coronavirus pandemic globally.
/ read more /
The European Medicines Agency’s (EMA’s) Committee for Human and Medicinal Products (CHMP) has recommended Veklury (remdesivir) be granted conditional marketing authorization in the European Union for the treatment of COVID-19.
/ read more /
More Industry News
|
|
|
Supplier News
Aji Bio-Pharma launched Ajility, a flexible platform for manufacturing vaccines and therapies.
/ read more /
|
|
|
|
advertisement
|
|
|
|
Honeywell Forge Cybersecurity Suite’s improved industrial-grade remote access and added protection and risk monitoring aids remote operations.
/ read more /
More Supplier News
|
|
advertisement
|
|
Bio/Pharma News
The company’s oral COVID-19 vaccine has been chosen to participate in a non-human primate challenge study organized and funded by Operation Warp Speed.
/ read more /
The company has expanded its laboratory test portfolio with five new molecular, serology, and functional assays for COVID-19 vaccine and therapy development programs.
/ read more /
More Bio/Pharma News
|
|
advertisement
|
|
| |
Regulatory News
FDA is placing emphasis on developing guidance documents more quickly and efficiently, and agency officials expect that such approaches may continue in the future.
/ read more /
The agency will be waiving fees for scientific advice for academia developing orphan drugs.
/ read more /
More Regulatory News
|
| |
|
Featured Topics |
|
MANUFACTURING
Data collected through the Industrial Internet of Things enable predictive maintenance.
/ read more /
|
|
| |
| |
|
PEER-REVIEWED RESEARCH
Research examined the effects of varying excipient and polymer weight in coatings designed to optimize the release of diclofenac sodium. The goal was to release it at night to improve the treatment of rheumatoid arthritis.
/ read more /
|
|
|
|
FORMULATION
Researching excipient grades and sources, as well as screening suppliers and materials, form the basis of programs to mitigate risk.
/ read more /
|
|
|
Events
July 20–22, 2020, Virtual
July 21–23, 2020, Virtual
August 24–26, 2020
more events
|
|
|
eBOOKS
 |
The Pharmacopoeia Compliance Series features a description of ways bio/pharma companies can participate in monograph development, a practical approach to pharmacopoeial compliance, and a summary of this 12-part series.
|
|
|
|
|
|
